Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Genfit’s Post-NASH Plans Center On ACLF, Cholestatic Liver Disease
May 12 2021
•
By
Joseph Haas
Genfit is moving on from NASH, into rare liver indications
More from Strategy
More from Business